论文部分内容阅读
无论是美国本土的上市公司,还是在美上市的非美国公司,包括目前在美国上市的70多家中国企业,都必须遵从萨班斯法案的规定,面临着同样巨大的考验。
Whether listed on the U.S. mainland or listed in the United States, including more than 70 Chinese enterprises currently listed in the United States, all must comply with the Sarbanes-Oxley Act and face the same tremendous test.